ACCESS Newswire
20 Sep 2022, 22:31 GMT+10
SAN FRANCISCO, CA / ACCESSWIRE / September 20, 2022 / Hagens Berman urges Kiromic BioPharma, Inc. (NASDAQ:KRBP) investors who purchased Kiromic shares to submit your losses now.
Class Period: June 25, 2021 - Aug. 13, 2021
Lead Plaintiff Deadline: Oct. 4, 2022
Visit: https://www.hbsslaw.com/investor-fraud/KRBP
Contact An Attorney Now: [email protected]
844-916-0895
Kiromic BioPharma, Inc. (KRBP) Securities Class Action:
The litigation focuses on Kiromic's statements about its development of two cancer treatment product candidates, ALEXIS-PRO-1 and ALEXIS-ISO-1, allowing it to issue 8 million shares at $40 per share to investors, which secondary offering closed on or about July 1, 2021.
More specifically, Kiromic represented that it had applications to begin human clinical trials for the two new drug candidates, known as Investigational New Drug ('IND') applications, pending with FDA, and that the Company could commence clinical trials within 30 days of those IND applications unless the FDA imposed a clinical hold.
Unbeknownst to investors, the Company had received communications from the FDA on June 16 and 17, 2021, informing it that the FDA was placing the IND applications for its two candidate products on clinical hold.
On July 16, 2021, two weeks after the closing of the ordering, Kiromic disclosed that it had received 'comments' from the FDA on its two IND applications.
Then, on Aug. 13, 2021, the Company clarified that the FDA had put the INDs on 'clinical hold.'
After the class period, on Jan. 27, 2022, the Company's CEO abruptly departed.
These events have driven the price of Kiromic shares sharply lower.
'We're focused on investors' losses and proving Kiromic misled investors by failing to disclose the June FDA clinical hold communications,' said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in Kiromic and have significant losses, or have knowledge that may assist the firm's investigation, click here to discuss your legal rights with Hagens Berman.
Whistleblowers: Persons with non-public information regarding Kiromic should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
# # #
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation law firm focusing on corporate accountability through class-action law. The firm is home to a robust securities litigation practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and fraud. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Contact:
Reed Kathrein, 844-916-0895
SOURCE: Hagens Berman Sobol Shapiro LLP
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationBASTROP, Texas: In a surprising turn at Elon Musk's X platform, CEO Linda Yaccarino announced she is stepping down, just months after...
NEW YORK CITY, New York: Former British prime minister Rishi Sunak will return to Goldman Sachs in an advisory role, the Wall Street...
LONDON, U.K.: Physically backed gold exchange-traded funds recorded their most significant semi-annual inflow since the first half...
AMSTERDAM, Netherlands: Some 32 percent of global semiconductor production could face climate change-related copper supply disruptions...
NEW YORK, New York - U.S. stocks rebounded Tuesday with all the major indices gaining ground. Markets in the UK, Europe and Canada...
NEW YORK CITY, New York: Financial markets kicked off the week on a cautious note as President Donald Trump rolled out a fresh round...
WASHINGTON, D.C.: An elaborate impersonation scheme involving artificial intelligence targeted senior U.S. and foreign officials in...
(Photo credit: Kamil Krzaczynski-Imagn Images) Kyle Manzardo was slated to bat cleanup and play first base for the Cleveland Guardians...
(Photo credit: Jerome Miron-Imagn Images) The Miami Marlins and Baltimore Orioles have been counted out for much of the past couple...
(Photo credit: Alex Gallardo-Imagn Images) The Seattle Sounders will be without their captain when they travel to Kansas City, Kan....
(Photo credit: Kamil Krzaczynski-Imagn Images) Thursday evening's contest between the host Chicago White Sox and Cleveland Guardians...